Bethany A Horsburgh1,2, Eunok Lee1,2, Bonnie Hiener1,2, John-Sebastian Eden1,2, Timothy E Schlub3, Susanne von Stockenstrom4, Lina Odevall4, Jeffrey M Milush5, Teri Liegler5, Elizabeth Sinclair5, Rebecca Hoh5, Eli A Boritz6, Daniel C Douek6, Remi Fromentin7, Nicolas Chomont7, Steven G Deeks5, Frederick M Hecht5, Sarah Palmer1,2. 1. Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney. 2. Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney. 3. Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. 4. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. 5. Department of Medicine, University of California San Francisco, California. 6. Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. 7. Centre de Recherche du CHUM and Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Canada.
Abstract
OBJECTIVE: The contribution of HLA-DR+ memory CD4 T cells to the HIV reservoir during prolonged antiretroviral therapy is unclear as these cells are commonly excluded when assessing for replication-competent HIV. To address this issue, we examined the distribution of genetically intact HIV DNA within HLA-DR- and HLA-DR+ memory CD4 T cells and the RNA transcriptional profile of these cells during antiretroviral therapy. DESIGN/ METHODS: Full-length DNA sequencing was used to examine the HIV DNA landscape within HLA-DR+ and HLA-DR- memory CD4 T cells. RNA quantification and sequencing was used to interrogate the relationship between HLA-DR status and HIV RNA transcription. RESULTS: HLA-DR+ CD4 T cells contained a high frequency of genetically intact HIV genomes, contributing over half of the genetically intact viral sequences to the reservoir. Expansions of genetically identical sequences were identified in all T-cell subsets, indicating that cellular proliferation maintains genetically intact and defective viral DNA during therapy. Intracellular HIV RNA levels in HLA-DR+ and HLA-DR- T cells were not statistically different by either long terminal repeat quantitative PCR quantification or single-genome RNA sequencing of the p6-RT region. CONCLUSION: The high proportion of intact viral DNA sequences in the proliferative HLA-DR+ subset suggests they are critical in maintaining HIV infection during effective therapy. As such, these cells should be included in any immune intervention targeting HIV during effective therapy.
OBJECTIVE: The contribution of HLA-DR+ memory CD4 T cells to the HIV reservoir during prolonged antiretroviral therapy is unclear as these cells are commonly excluded when assessing for replication-competent HIV. To address this issue, we examined the distribution of genetically intact HIV DNA within HLA-DR- and HLA-DR+ memory CD4 T cells and the RNA transcriptional profile of these cells during antiretroviral therapy. DESIGN/ METHODS: Full-length DNA sequencing was used to examine the HIV DNA landscape within HLA-DR+ and HLA-DR- memory CD4 T cells. RNA quantification and sequencing was used to interrogate the relationship between HLA-DR status and HIV RNA transcription. RESULTS: HLA-DR+ CD4 T cells contained a high frequency of genetically intact HIV genomes, contributing over half of the genetically intact viral sequences to the reservoir. Expansions of genetically identical sequences were identified in all T-cell subsets, indicating that cellular proliferation maintains genetically intact and defective viral DNA during therapy. Intracellular HIV RNA levels in HLA-DR+ and HLA-DR- T cells were not statistically different by either long terminal repeat quantitative PCR quantification or single-genome RNA sequencing of the p6-RT region. CONCLUSION: The high proportion of intact viral DNA sequences in the proliferative HLA-DR+ subset suggests they are critical in maintaining HIV infection during effective therapy. As such, these cells should be included in any immune intervention targeting HIV during effective therapy.
Authors: Ross A Pollack; R Brad Jones; Mihaela Pertea; Katherine M Bruner; Alyssa R Martin; Allison S Thomas; Adam A Capoferri; Subul A Beg; Szu-Han Huang; Sara Karandish; Haiping Hao; Eitan Halper-Stromberg; Patrick C Yong; Colin Kovacs; Erika Benko; Robert F Siliciano; Ya-Chi Ho Journal: Cell Host Microbe Date: 2017-04-12 Impact factor: 21.023
Authors: Zheng Wang; Evelyn E Gurule; Timothy P Brennan; Jeffrey M Gerold; Kyungyoon J Kwon; Nina N Hosmane; Mithra R Kumar; Subul A Beg; Adam A Capoferri; Stuart C Ray; Ya-Chi Ho; Alison L Hill; Janet D Siliciano; Robert F Siliciano Journal: Proc Natl Acad Sci U S A Date: 2018-02-26 Impact factor: 11.205
Authors: Szu-Han Huang; Yanqin Ren; Allison S Thomas; Dora Chan; Stefanie Mueller; Adam R Ward; Shabnum Patel; Catherine M Bollard; Conrad Russell Cruz; Sara Karandish; Ronald Truong; Amanda B Macedo; Alberto Bosque; Colin Kovacs; Erika Benko; Alicja Piechocka-Trocha; Hing Wong; Emily Jeng; Douglas F Nixon; Ya-Chi Ho; Robert F Siliciano; Bruce D Walker; R Brad Jones Journal: J Clin Invest Date: 2018-01-22 Impact factor: 14.808
Authors: M Kearney; F Maldarelli; W Shao; J B Margolick; E S Daar; J W Mellors; V Rao; J M Coffin; S Palmer Journal: J Virol Date: 2008-12-30 Impact factor: 5.103
Authors: Francesco Andrea Procopio; Rémi Fromentin; Deanna A Kulpa; Jessica H Brehm; Anne-Gaelle Bebin; Matthew C Strain; Douglas D Richman; Una O'Doherty; Sarah Palmer; Frederick M Hecht; Rebecca Hoh; Richard J O Barnard; Michael D Miller; Daria J Hazuda; Steven G Deeks; Rafick-Pierre Sékaly; Nicolas Chomont Journal: EBioMedicine Date: 2015-06-27 Impact factor: 8.143
Authors: Lina Josefsson; Susanne von Stockenstrom; Nuno R Faria; Elizabeth Sinclair; Peter Bacchetti; Maudi Killian; Lorrie Epling; Alice Tan; Terence Ho; Philippe Lemey; Wei Shao; Peter W Hunt; Ma Somsouk; Will Wylie; Daniel C Douek; Lisa Loeb; Jeff Custer; Rebecca Hoh; Lauren Poole; Steven G Deeks; Frederick Hecht; Sarah Palmer Journal: Proc Natl Acad Sci U S A Date: 2013-11-25 Impact factor: 11.205
Authors: Susanne Eriksson; Erin H Graf; Viktor Dahl; Matthew C Strain; Steven A Yukl; Elena S Lysenko; Ronald J Bosch; Jun Lai; Stanley Chioma; Fatemeh Emad; Mohamed Abdel-Mohsen; Rebecca Hoh; Frederick Hecht; Peter Hunt; Ma Somsouk; Joseph Wong; Rowena Johnston; Robert F Siliciano; Douglas D Richman; Una O'Doherty; Sarah Palmer; Steven G Deeks; Janet D Siliciano Journal: PLoS Pathog Date: 2013-02-14 Impact factor: 6.823
Authors: C Korin Bullen; Gregory M Laird; Christine M Durand; Janet D Siliciano; Robert F Siliciano Journal: Nat Med Date: 2014-03-23 Impact factor: 53.440
Authors: Katie Fisher; Xiao Qian Wang; Ashley Lee; Vincent Morcilla; Anneke de Vries; Eunok Lee; John-Sebastian Eden; Steven G Deeks; Anthony D Kelleher; Sarah Palmer Journal: J Virol Date: 2022-03-23 Impact factor: 5.103
Authors: Charline Bacchus-Souffan; Mark Fitch; Jori Symons; Mohamed Abdel-Mohsen; Daniel B Reeves; Rebecca Hoh; Mars Stone; Joseph Hiatt; Peggy Kim; Abha Chopra; Haelee Ahn; Vanessa A York; Daniel L Cameron; Frederick M Hecht; Jeffrey N Martin; Steven A Yukl; Simon Mallal; Paul U Cameron; Steven G Deeks; Joshua T Schiffer; Sharon R Lewin; Marc K Hellerstein; Joseph M McCune; Peter W Hunt Journal: PLoS Pathog Date: 2021-01-19 Impact factor: 6.823
Authors: Vincent Morcilla; Charline Bacchus-Souffan; Katie Fisher; Bethany A Horsburgh; Bonnie Hiener; Xiao Qian Wang; Timothy E Schlub; Mark Fitch; Rebecca Hoh; Frederick M Hecht; Jeffrey N Martin; Steven G Deeks; Marc K Hellerstein; Joseph M McCune; Peter W Hunt; Sarah Palmer Journal: mBio Date: 2021-09-21 Impact factor: 7.867
Authors: Jason Neidleman; Xiaoyu Luo; Julie Frouard; Guorui Xie; Feng Hsiao; Tongcui Ma; Vincent Morcilla; Ashley Lee; Sushama Telwatte; Reuben Thomas; Whitney Tamaki; Benjamin Wheeler; Rebecca Hoh; Ma Somsouk; Poonam Vohra; Jeffrey Milush; Katherine Sholtis James; Nancie M Archin; Peter W Hunt; Steven G Deeks; Steven A Yukl; Sarah Palmer; Warner C Greene; Nadia R Roan Journal: Elife Date: 2020-09-29 Impact factor: 8.140
Authors: Chantelle L Ahlenstiel; Geoff Symonds; Stephen J Kent; Anthony D Kelleher Journal: Front Cell Infect Microbiol Date: 2020-08-14 Impact factor: 5.293
Authors: Ronald J Ellis; Jennifer E Iudicello; Robert K Heaton; Stéphane Isnard; John Lin; Jean-Pierre Routy; Sara Gianella; Martin Hoenigl; Rob Knight Journal: Viruses Date: 2021-09-22 Impact factor: 5.048